NY A 3973
in committeeRelates to prescription drug formulary coverage for interchangeable biologics and biosimilars
New York · 2025-2026 Regular Session · lower
Quick answers
Did NY A 3973 pass?
Not yet. NY A 3973 is in committee as of 2026-05-07 and has not come to a final vote. Latest recorded action (2026-05-07): ADVANCED TO THIRD READING CAL.450
What is NY A 3973 about?
Relates to prescription drug formulary coverage for interchangeable biologics and biosimilars.
Who sponsors NY A 3973?
John T. McDonald III is the primary sponsor of NY A 3973, joined by 4 cosponsors.
Description
Relates to prescription drug formulary coverage for interchangeable biologics and biosimilars.
- Introduced
- —
- Latest action
- 2026-05-07 — ADVANCED TO THIRD READING CAL.450
- Bill type
- bill
- Last updated
- —
Sponsors
- John T. McDonald IIIprimary
- Jonathan Jacobsoncosponsor
- Brian Manktelowcosponsor
- Keith Browncosponsor
- Steven Otiscosponsor
Committees
Not provided by source.
Action timeline
2025-01-30
REFERRED TO INSURANCE
referral-committee
2025-06-02
AMEND AND RECOMMIT TO INSURANCE
amendment-passage,referral-committee
2025-06-02
PRINT NUMBER 3973A
amendment-passage
2025-06-08
REFERENCE CHANGED TO WAYS AND MEANS
referral-committee
2025-06-09
REPORTED REFERRED TO RULES
referral-committee
2026-01-07
REFERRED TO WAYS AND MEANS
referral-committee
2026-05-05
REPORTED
2026-05-07
ADVANCED TO THIRD READING CAL.450
Versions
Documents
Votes
Not provided by source.
Related bills
- Prior session: A 9055not in this corpus
- Companion bill: S 3485
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 3973. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.